President and CEO Robert Blum describes aficamten's mechanism, the trial's study design, and reflects on Cytokinetics' journey of 25 years in drug development.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
.png){kind=logo}
